drugset / Trial / NCT00882960

Intranasal Fentanyl for Pain Management

NCT00882960 ↗

Phase 4 Unknown 500 enrolled Genesys
RandomizedParallel-groupOpen-labelTreatment

Summary

Goal of the research will be to demonstrate a reduction in reported pain following the atomization and intra-nasal administration of Fentanyl versus the reduction in pain achieved from intravenous Fentanyl. It is hypothesized that pain should be reduced following fentanyl administration using the intra-nasal atomization equal to the intravenous delivery.

Timeline

Start
2009-04
Primary completion
2012-04
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fentanyl Other / unclassified 50 ug Intravenous

Indications

No indication recorded.